2016 ESMO Annual Congress
The European Society for Medical Oncology Annual Congress at the Bella Center in Copenhagen, Denmark, from October 7 to 11, 2016.
The Role of Lenvatinib in NSCLC Treatment
Lars Bastholt, MD
The Rationale Behind CheckMate-275 in Metastatic Bladder Cancer
Matthew Galsky, MD
Results of Phase II mUC Trial Support Approval of Nivolumab Applications
Virginia Powers, PhD